Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.727,14
0,00%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Indaptus Therapeutics Inc (INDP) Indaptus Therapeutics Inc (INDP) Notizie

Indaptus Therapeutics Inc

INDP
2,7699
0,2899 (11,69%)
01 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/5/202414:00GLOBEIndaptus Therapeutics to Present at the Jefferies Global..
29/5/202414:00GLOBEIndaptus Therapeutics to Present New Cohort Data Confirming..
22/5/202414:00EDGAR2Form 8-K - Current report
22/5/202414:00GLOBEIndaptus Therapeutics Announces Completion of First Patient..
08/5/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:05EDGAR2Form 8-K - Current report
08/5/202414:00GLOBEIndaptus Therapeutics Reports First Quarter 2024 Financial..
11/4/202413:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
28/3/202413:00GLOBEIndaptus Therapeutics to Present at the MedInvest Biotech..
25/3/202413:30GLOBEIndaptus Therapeutics Previews Positive Mechanism of Action..
18/3/202413:00GLOBEIndaptus Therapeutics to Participate in Tribe Public Webinar..
13/3/202412:30GLOBEIndaptus Therapeutics Reports Fourth Quarter and Year-End..
04/3/202417:01EDGAR2Form 8-K - Current report
04/3/202413:30GLOBEIndaptus Therapeutics Announces Positive Results from Second..
15/2/202414:00GLOBEIndaptus Therapeutics to Present at the 2024 BIO CEO &..
08/2/202414:00GLOBEIndaptus Therapeutics Expands Digital Presence with Launch..
23/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEEuropean Patent Office Approves Key Patent for Indaptus..
06/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:05EDGAR2Form 8-K - Current report
06/11/202322:01GLOBEIndaptus Therapeutics Reports Third Quarter 2023 Financial..
06/11/202314:13EDGAR2Form 8-K - Current report
06/11/202314:00GLOBEIndaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune..
31/10/202314:12EDGAR2Form 8-K - Current report
31/10/202314:01GLOBEIndaptus Therapeutics to Present Positive Pharmacodynamic..
27/9/202314:00GLOBEIndaptus Therapeutics to Present at the LD Micro Main Event..
26/9/202314:00GLOBERegistration Is Now Open For Tribe Public’s Webinar Event..
19/9/202314:00GLOBEIndaptus Therapeutics Doses First Patient in Second Cohort..
06/9/202314:05GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 25th..
17/8/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202314:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:10EDGAR2Form 8-K - Current report
14/8/202314:00GLOBEIndaptus Therapeutics Reports Second Quarter 2023 Financial..
10/8/202314:45EDGAR2Form 8-K - Current report
10/8/202314:45GLOBEIndaptus Therapeutics Announces Opening of Next Cohort in..
07/8/202314:00GLOBEIndaptus Therapeutics Appoints Industry Veteran Roger..
15/6/202314:00GLOBEIndaptus Therapeutics to Participate in the Maxim Group..
Apertura: 2,50 Min: 2,354 Max: 2,50
Chiusura: 2,48

La tua Cronologia

NASDAQ
INDP
Indaptus Therapeutics
USOTC
CLSH
CLS Holdings USA (QB)
BIT
ENI
Eni
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network